BKNG

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

✓

Return

+0.23%

Status

scored

Maintain BKNG at 0.95-1.00x benchmark weight (small UW tilt, effectively Hold) with a $140 hard stop, respecting the binding 10/07 lesson that prior UW at 0.85-0.90x cost +3.1% of relative outperformance when the technical breakdown resolved favorably. Adopt the Neutral Analyst's flexible add framework (break above $176 Bollinger band on 5M+ volume; flush to $150-155 with positive divergence) in lieu of a rigid $186-only trigger. Q3 earnings is the binary catalyst—reassess sizing and trajectory immediately post-print, with a $165 price target over 3-6 months.

Outcome

✗

Return

+2.63%

Status

scored

Trim BKNG to 0.85-0.90x benchmark weight (~10-15% reduction) at market near $155.87, rejecting all calls for full long positioning or zero exposure. The recommendation blends the 10/06 lesson that bearish technicals/macro/unvalidated earnings warrant meaningful underweight tilt, with the 10/05 lesson that sub-13x fwd P/E with 0.87 PEG creates a re-rate floor that prevents going to 0.65-0.75x territory. Re-engagement to 1.0x weight requires Q3 earnings resolution—either close above 50 SMA at $187.46 with volume ≥1.5x, or a clean beat-and-raise with forward EPS >$12.50 and no incremental Muse commentary.

Outcome

✓

Return

-1.12%

Status

scored

Re-engaging BKNG to 0.95-1.00x benchmark weight (small UW tilt, effectively Hold) from 0.65-0.75x UW, citing the 10/05 lesson that at sub-13x forward P/E (12.75x) with PEG under 1.0 (0.87), the multiple-expansion floor is empirically tighter than technical breakdown downside. Rejecting Aggressive/Research Manager Buy/Overweight as pre-committing ahead of the Q3 binary catalyst (~5 weeks out), while rejecting conservative 1% starter as inconsistent with the re-rate floor thesis; the 0.95-1.00x band captures the floor without violating the 9/23 lesson against adding into breakdown.

Outcome

✓

Return

-0.44%

Status

scored

Trim BKNG to 0.65-0.75x benchmark weight at market near $157.50 (25-35% reduction from current underweight tilt), with the hedge shifting to 3-4% notional in $145 puts (December expiry). Hard inversion at confirmed close below $148.50 on volume >8M shares escalates sizing to 0.55-0.65x. Re-engagement to 1.0x benchmark weight requires Q3 beat-and-raise with forward EPS >$12.50 and no incremental Muse commentary, with 2-4 month tactical horizon anchored to early November earnings.

Outcome

✓

Return

-0.43%

Status

scored

Portfolio manager implements a small calibrated UNDERWEIGHT at 0.80–0.90x benchmark weight (10–20% trim from current exposure), rejecting the committee's four-vote HOLD consensus in favor of the empirically-validated tilt based on decision history showing benchmark neutrality produced -1.5% alpha drag at this exact configuration on 10/01. The $151 stop loss and $145 put hedge (3–4% of post-trim notional) are preserved, with re-engagement triggers tied to Q3 2026 earnings resolution, technical reversal signals, or macro dovish pivot—price target is $148.00 over a 2–4 month tactical horizon anchored to the early November earnings catalyst.

Outcome

✓

Return

-0.79%

Status

scored

Maintain BKNG at benchmark weight; avoid initiating fresh longs at ~$160 or trimming into the buyback floor. Re-engage only on defined confirmation triggers: 50 SMA reclaim at $189.53 with volume ≥1.5x 20-day average (preferred), base hold at $150-160 for 5+ trading days with RSI >50 and MACD bullish cross (secondary), or Q3 beat-and-raise with fwd EPS >$12.50 and no incremental Muse commentary (tertiary).

Outcome

✓

Return

-1.61%

Status

scored

Trim BKNG to 0.55-0.65x benchmark weight (~40-45% reduction from current UW tilt) by executing at market near $162.50, rejecting the Research Manager and Trader BUY proposals that violate the binding 9/23 reflection. Express tail protection via a $150-160 put spread, with hard invalidation at $148 close on volume >8M shares and re-engagement only on confirmed close above 200 SMA ($182-184) with MACD histogram contracting AND RSI >40, over a 2-4 month tactical horizon anchored to Q3 2026 earnings as the binary resolution event.

Outcome

✗

Return

+0.35%

Status

scored

Trim BKNG to 0.70-0.75x benchmark weight (25-30% reduction) at market near $162, with tail protection via a $150-160 put spread (December expiry) sized to 100-150 bps of residual position; the Underweight direction is correct based on hostile macro regime, compressed risk premium, broken technicals, and falsified buyback floor, but magnitude should anchor to the structural floor rather than the signal cluster to avoid bleeding alpha in drift regimes. Hard invalidation at $148 close on volume >8M shares; re-engage only on confirmed close above 200 SMA ($182-184) with MACD histogram contracting and RSI >40.

Outcome

✓

Return

-0.93%

Status

scored

Trim BKNG to 75-85% of benchmark weight (~15-25% trim) using a split framework: half in the current $163-167 range and half on any relief rally to $172-175 (10 EMA zone) with a 5-trading-day time stop, hard stop at $155.90; express the bearish view via cheaper puts rather than heavy outright trim to preserve reversal capture if Q3 2026 earnings validates the conservative frame and Muse proves non-disruptive.

Outcome

✗

Return

-0.05%

Status

scored

Maintain Underweight on BKNG with a targeted trim to 0.75-0.85x benchmark weight (~1.25% portfolio) using split execution—half at market near $164 and remainder on a $172-175 limit order with a 5-trading-day time stop—while setting a hard stop at $150; the position avoids redundant put hedges since the trim itself serves as the primary defense against Muse disintermediation risk, macro headwinds from hawkish rates, and broken technicals, while preserving re-engagement optionality if Q3 2026 earnings validates the floor hold.

Outcome

✗

Return

+4.15%

Status

scored

Maintain BKNG at current benchmark weight with a Hold rating and $190 price target contingent on Q3 2026 earnings confirmation. Do not add fresh longs at $157 ahead of the binary catalyst; instead, sell cash-secured puts at $130-140 strikes to monetize elevated implied volatility while preserving dry powder for re-engagement after confirmation. The binding 9/23/26 decision history shows Hold is alpha-preserving in this exact configuration (quality compounder, RSI sub-25, unvalidated structural threat), with prior Underweight attempts losing alpha and adding into breakdowns alpha-decaying in 4 of 8 prior decisions.

Outcome

✓

Return

+0.97%

Status

scored

Maintain BKNG at benchmark weight as three analyst frameworks converge on Hold for different reasons: Aggressive Analyst sees PEG 0.61 and buyback accretion, Conservative Analyst cites broken technicals and unvalidated Muse risk, and Neutral Analyst demands defined triggers. The $150.80 Bollinger lower band break on >8M shares would trigger reassessment to Underweight at 0.75-0.85x, while re-engagement requires closing above $169.87 (10 EMA) with MACD histogram contracting and RSI curling above 35.

Outcome

✓

Return

-5.07%

Status

scored

The calibrated Underweight at 0.75-0.85x benchmark weight with 100-150 bps put hedge is the only framework that simultaneously anchors magnitude to the floor per 9/18, sizes puts for drift capture per 9/21 explicit correction, preserves re-engagement optionality via defined invalidation triggers, and respects the structural floor ($17B cash, $9B FCF, deferred revenue) without donating asymmetric reversal capture. Execution should be staged: 50% trim in $164-$172 range, remaining 50% on relief rally to $175-$180 zone.

Outcome

✓

Return

-2.55%

Status

scored

Reduce BKNG to 0.75-0.85x benchmark weight (15-25% trim) anchored to structural floor rather than heavier 40-50% trim, per the binding 9/18 reflection. Express residual bearish view via closer-to-money puts at the $170 strike for November expiry to capture drift decay, avoiding naked Hold bleed demonstrated in 9/14 and 9/16 reflections. Invalidation requires $195 close on volume >7M shares AND RSI >50 AND MACD histogram contracting simultaneously.

Outcome

–

Return

+0.37%

Status

scored

Reduce BKNG to 0.55-0.65x benchmark weight (35-45% trim) via three tranches across the $176-$192 relief-bounce zone, with hard thesis-invalidation stop at $200 and active structural stop at $168 close on >8M shares. The Underweight verdict synthesizes bearish technicals (MACD -2.76, 200 SMA breached at $166.90, RSI 27.58 for three sessions) with a binding floor constraint — fundamental floor ($17.2B cash, $9B FCF, 34% operating margins, 7%+ shareholder yield) is pressured but not demonstrably impaired, capping trim at 0.55-0.65x rather than full Sell.

Outcome

✓

Return

-1.54%

Status

scored

Trim BKNG by 40-50% toward 0.50-0.60x benchmark weight from current levels ($170.52), with no new long exposure at current prices. Retain reduced residual sized to absorb downside to the $152 June 2025 low zone, with hard thesis-invalidation stop at $184 (200 SMA reclaim) and active structural stop on residual at $168 (Sep 17 intraday low).

Outcome

✓

Return

-0.51%

Status

scored

Maintain BKNG at benchmark weight with protective put hedge ($162 strike, ~5% OTM, 4-6 week expiry) as two consecutive Underweight tilts (9/11, 9/9) failed and the fundamental floor remains intact ($17.2B cash, 0.28× net leverage, $9B FCF, 0.65 PEG). Re-engagement requires two of four triggers (200 SMA reclaim above $184, MACD histogram contracts toward -2.0, RSI curls above 35, OR oil retraces below $95) with hard stop at $158; Q3 earnings in late October/early November is the binary resolution event.

Outcome

✓

Return

+0.05%

Status

scored

Maintain BKNG at current benchmark weight with a HOLD rating, implementing a protective put hedge ($164-168 strike, 4-6 week expiry) to cap downside risk while preserving upside exposure. Do not add at current $171-175 levels or trim ahead of confirmation, with re-engagement triggers set for upside (daily close above 10 EMA at $181.81 with RSI >40 and MACD contracting, or Q3 earnings beat-and-raise) and downside value-add (test of $153-157 on volume capitulation).

Outcome

✓

Return

-2.30%

Status

scored

Maintain BKNG at benchmark weight with protective put hedge ($165-168 strike, 4-6 week expiry) as the 9/11 reflection explicitly overrides Underweight for capitulation setups with intact fundamental floors—the $17.2B cash, $9B FCF, and 0.64 PEG indicate structural health rather than impairment. Add exposure only on $168 volume capitulation or confirmed weekly close above $193 50-SMA with volume; the hedge prevents the ~1%/week alpha bleed that naked Hold produced in prior hostile-regime decisions.

Outcome

✗

Return

+0.82%

Status

scored

BKNG is trimmed to 0.70-0.80x benchmark weight (20-30% reduction) with execution on relief bounces toward $180-185 rather than capitulation flush at $173.92, with a $167.50 hard stop and protective put hedge ($168-170 strike, 4-6 week expiry). The Underweight rating is supported by MACD at -5.69 (deepest in lookback), broken 200 SMA, RSI 30.05 with no confirmed bullish divergence, and a fresh EU antitrust ruling (€1.63B ETraveli block) as structural headwind, overriding the Research Manager's Buy and Trader's Buy signals.

Outcome

✓

Return

-0.24%

Status

scored

Maintain Booking Holdings (BKNG) at Hold with protective put hedge instead of trimming or selling, as the 9/9/2026 reflection explicitly overrides Underweight/Sell calls at this capitulation level. The hedge (1.5-2% of position value, $168-170 strike, 4-6 week expiry) caps downside while preserving full upside into Q3 2026 earnings. Re-engage on 10 EMA reclaim at $189 with volume >7M or Q3 beat-and-raise; escalate to Underweight on confirmed close below $170 on volume >9M shares.

Outcome

✗

Return

+0.52%

Status

scored

The portfolio manager trims BKNG to 0.65-0.70x benchmark weight (30-35% reduction), citing prior decision fingerprint data showing Underweight outperforms Hold on this name in the current regime. Execution should occur on relief bounces toward $185-190, with hard stop at $148; re-engagement requires either a confirmed close above $208 on volume >7M shares with MACD histogram flipping positive, or a Q3 earnings beat-and-raise against trimmed guidance.

Outcome

✗

Return

-3.81%

Status

scored

Maintain existing BKNG exposure at benchmark weight without adding or trimming. The 200 SMA at $185.29 has been broken (current close $180.30), but a capitulation candle with RSI at 32.80 and 10.5M shares volume argues for waiting rather than acting. Macro conditions are deteriorating with oil hitting $95 and Fed hike odds above 60%, yet the fundamental floor is unimpeachable with Forward P/E of 14.57×, $17.2B cash, and ~7% capital return yield. The Q3 2026 earnings catalyst in early November provides the natural resolution point for this tactical position.

Outcome

✓

Return

-6.72%

Status

scored

Trim BKNG to approximately 0.80-0.85x benchmark weight (15-20% reduction from current sizing) over the next 1-3 sessions on relief bounces toward $199-201, as the 9/2 escalation rule is triggered by confirmed MACD divergence (-2.91 histogram), multi-session distribution volume (5-7M shares), and RSI not oversold at 41.9 — meaning capitulation has NOT arrived to reset the compression clock. The fundamental floor ($9B FCF, $17B cash, 7%+ shareholder yield) constrains the trim to 0.80-0.85x rather than full Sell, with Q3 2026 earnings in early November serving as the binary resolution catalyst.

Outcome

–

Return

-0.94%

Status

scored

Trim BKNG position 15-20% to 0.80x benchmark weight over 1-3 sessions, selling into relief bounces toward $199-201 rather than capitulation, with a hard stop at $187. This calibrated Underweight honors the 9/2 escalation lesson (meaningful reduction demanded) while respecting the 9/1 constraint (lighter magnitude warranted absent fresh catalyst), targeting early-November Q3 2026 earnings as the binary resolution event.

Outcome

✗

Return

-2.24%

Status

scored

Maintain BKNG at existing core weight with no fresh capital deployment at current levels; implement a protective put hedge ($195-197 strike, 3-4 week expiry, 1-2% of position value) to cap downside given unresolved technical compression with MACD histogram at -2.69 and RSI at 47.67. Tactical adds capped at 10-15% only on confirmed close above $203.97 with above-average volume and RSI >50, with trim targets at $208.50 and $214.40, and full review anchored to early-November Q3 2026 earnings as the binary catalyst resolution.

Outcome

✗

Return

+2.00%

Status

scored

Maintain Underweight rating with 25-30% trim of BKNG into the $200-205 resistance zone, targeting 80-85% benchmark weight; do not deploy new capital. Hard invalidation is a confirmed close below $185 on expanding volume, with re-engagement warranted only on confirmed close above $208 with volume exceeding 7M shares coinciding with Q3 earnings validation, or capitulation flush to $185-190 with positive momentum divergence.

Outcome

✓

Return

-1.71%

Status

scored

Analysts unanimously maintain HOLD at existing weight for BKNG, with the 8/27 Underweight call producing +1.7% alpha against the position serving as the key calibration lesson—fingerprint pattern-matching without confirmed catalysts costs alpha. The fundamental case remains unimpeachable (16% revenue CAGR, 34% operating margins, 20%+ ROA, forward P/E 16.09×), but the tactical setup is too weak for fresh capital deployment, justifying the HOLD that honors both the quality argument and the deteriorating momentum. Re-engagement to Buy requires confirmed close above $214.42 on volume exceeding 7M shares, while re-engagement to Underweight requires confirmed close below $191.80 on more than 2× average volume.

Outcome

✓

Return

-3.18%

Status

scored

Analysts recommend trimming 15-20% of BKNG exposure at current levels (~$205-206) to 80-85% of benchmark weight, calibrating the Underweight position between an aggressive 25-33% trim and a conservative Hold. The sizing honors the 8/27 lesson that fingerprint-matching Underweights should avoid overcommitment, while still acknowledging deteriorating momentum (MACD histogram at -1.73, price below both 10 EMA and VWMA) without abandoning a structurally sound position ($7.7B annual FCF, $15.5B annualized buybacks, PEG 0.94). Re-engagement criteria require either a confirmed reclaim above $210 with MACD histogram improvement, or a capitulation flush to $185-190 with basing structure, with a hard mental stop at $191.50.

Outcome

✗

Return

+1.52%

Status

scored

Maintain Underweight at 60-70% benchmark weight as the 8/26 call was correct (-3.7% alpha vs SPY) and technical setup has worsened since—MACD deepened to -1.55, two failed $213 bounces confirm distribution, RSI at 49.93 with 50-breakdown risk. Trim 10-15% into $213-215 rallies (failed retest supply zone) and consider 1-2% tactical put hedge through Jackson Hole; re-engage only on $185-190 basing with higher lows on rising volume and momentum divergence, or >$215.69 close on >7M volume with Q3 deferred-revenue validation.

Outcome

✓

Return

-3.03%

Status

scored

Underweight BKNG at 60-70% benchmark weight with all three analysts converging on near-term setup worsening despite the Conservative's structural bull thesis. Three-point analytical consensus drives the verdict: all analysts agree on near-term deterioration, the Research Manager's capital return/FCF divergence evidence ($8.42B returns vs $6.75B FCF, 94% QoQ net debt increase) is dispositive, and the trader's SELL order structure ($215 sell / $225 stop) is mechanically inconsistent with a long trim. Execution: trim 25-30% on rallies into $213-218 zone, NOT at current levels, with Q3 earnings in early November as the catalyst that determines whether the trimmed guide is a deceleration floor or structural plateau.

Outcome

✗

Return

-2.29%

Status

scored

Maintain core BKNG position at $213.78 with HOLD rating while explicitly refusing to add at current levels (12.5% above 50 SMA following a 43% three-month rally with bearish MACD cross). Deploy a covered-call overlay at $220-225 strike (1-2 month tenor) to monetize the elevated implied vol and convert passive observation into active income harvest. Two-tier warning framework triggers: alert state at close below $208 with expanding volume (no adds), formal trim at confirmed close below $204 sized 25-50% discretionally, with explicit trim-on-strength taking 20-30% off at the $240-245 zone where options market is already capping upside.

Outcome

✓

Return

+0.20%

Status

scored

Maintain BKNG at $213.36 with disciplined, action-defined execution rather than passive maintenance; do NOT initiate or add at current levels with entry zone at $190-200 requiring technical confirmation. Cut initial sizing to 3-5% given ATR expansion to 6.71 and macro tail risk, with hard stop at $185 and layered invalidation exits at $189 (50 SMA trend-break) and $204.91 (formal trim). A covered call overlay at $220-225 strike (1-2 month tenor) harvests the 11% implied vol while waiting for Q3 2026 earnings catalyst in early November.

Outcome

✓

Return

+1.78%

Status

scored

Build a measured 2.5-3% position in BKNG through two tranches: an initial 1.5% pilot at $205-207 (10 EMA zone), then add 1-1.5% on confirmed daily close above $214.42 with RSI above 60. The structural setup is bullish (rising 200/50 SMAs, Q2 operating leverage at +11.1% on revenue +8.2%, fortress margins at 87% gross/25.5% net) with Q3 seasonality tailwind, but short-term momentum is weakened (negative MACD histogram for five sessions) and reward-to-risk is modest at 1.1-1.4:1 rather than the claimed 4.5:1. Exit triggers are explicit: trim 50% if no new high in four weeks; full exit on close below $200 on rising volume.

Outcome

✓

Return

-0.12%

Status

scored

Analyst maintains Underweight on BKNG, recommending a 40-50% position trim executed in two tranches: 25% at current levels ($209-211) and an additional 15-25% into the $213-218 resistance zone, with a covered-call overlay on the residual 50-60% core position using $220-225 strikes and 1-2 month tenor to monetize the 11% implied vol. Hard stop on residual at $195 close, with re-engagement conditional on confirmed basing at $185-190 with the 50/200 SMA cluster holding.

Outcome

✓

Return

-1.47%

Status

scored

Hold BKNG core position at ~$213 with active hedging discipline—do not add at current elevated levels. Define a shallow-pullback add zone at the 10 EMA ($208.40) with a confirmation filter (close holding above 10 EMA after test, RSI >50), stop at $200 for new tranches (~5% risk). Trim 25-30% on a $220 test that produces a shooting star or bearish engulfing candle, while holding full position on confirmed close above $220 with volume.

Outcome

✓

Return

+2.28%

Status

scored

Maintain existing BKNG core position unchanged at $208 and do not deploy fresh capital at current levels, where the reward-to-risk ratio is mediocre at 0.77 (8.5% upside vs. 11% downside). Scale new adds at $194-199 (SMA cluster zone) where reward-to-risk becomes favorable at 1.5-2.0:1, with stops below $184. Q3 earnings is the operative catalyst that will either validate the 37% implied forward-EPS growth or collapse the current symmetric risk-reward setup.

Outcome

✓

Return

+1.70%

Status

scored

Initiating a measured BUY in BKNG at $204, deploying 25-30% of target weight (~0.5% portfolio) with max 2% via confirmation-based triggers. Current setup differs materially from prior overbought-extension failures (RSI 71-73, price above 10 EMA) — here RSI is 59, 10 EMA is broken for first time in 13 sessions, and entry is 11% below prior decision points. Hard structural stop at $178-182 (50/200 SMA confluence), explicitly rejecting trader's $170 and conservative's $190 as structurally nonsensical. Price target $230 over 12-18 months, with scaling triggers at $207-210 (ADD 30%) and $190-198 (ADD 30-40%).

Outcome

✗

Return

-3.44%

Status

scored

Maintain BKNG at Hold with covered-call hedging at $220-225 strikes (1-2 month expiry) to monetize elevated IV and cap upside, given the unconfirmed golden cross and 39% rally already pricing in re-rating. Do not add at current levels; preferred add zone is $195-205 on rising 50 SMA confirmation, with structural stop at $195.

Outcome

✓

Return

-0.60%

Status

scored

Analysts recommend a tactical trim of 30–40% of BKNG in the $214–220 zone, where overbought RSI divergence, MACD histogram contraction (~20% in two sessions), and upper Bollinger band resistance converge after a parabolic +22.8% rally in 13 sessions. Hard invalidation sits at $194; trim-completion stop at $221.55; re-entry requires either breakout above $221.55 on >2× average volume with MACD expansion, or pullback to $200–205 with RSI reset to 55–60. The 12-month fair value range is $190–210 with a $200 price target.

Outcome

✓

Return

-0.29%

Status

scored

Maintain existing BKNG core position at $213 without deploying fresh capital at current levels. Stage new tranches at $204 (1/3), $200 (1/3), and final 1/3 on confirmed re-acceleration with RSI reset to 55-60 and price above 20-day high. Hard stop at $199.50 (~6% below spot) provides ~1.8× ATR volatility envelope protection. The Hold rating is supported by declining volume (68% drop from Aug 5 spike), failed upper Bollinger Band test at $219.10, and mixed sentiment (6.3/10 with LOW confidence). Prior 2026-08-07 Overweight call produced -0.7% alpha in identical technical setup, while the 2026-08-10 Hold produced +0.3% alpha, confirming patience preserves capital.

Outcome

✓

Return

-0.00%

Status

scored

The portfolio manager maintains a HOLD rating on BKNG, preserving the existing core position without adding at the current $212.88 level. The decision prioritizes patience over conviction, citing identical technical warning signs (RSI 73, Bollinger tag, +18% above 50 SMA, no confirmed MA cross) that produced -0.7% alpha on a prior 2026-08-07 Overweight call in this same setup.

Outcome

✗

Return

-0.72%

Status

scored

Initiate a 1.0% core position in BKNG at ~$212.50 with staged adds of 1.0% at $199–207 and 1.0% at $185–195 (with confirmed macro catalyst), capping total exposure at 3.0%. Raise the hard stop to $185 (just above the 200 SMA at $184.77), tightening the plan's $179 floor as the prior 50 SMA has been overtaken and no longer represents the operative trend reference. The $230–250 base case target reflects continued buyback-supported compounding at a reasonable multiple, with the Overweight rating justified by the buyback floor and confirmed uptrend despite technically extended conditions.